Van Brabandt H - Search Results

1

Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.

Neyt M, De Laet C, Van Brabandt H, Franco O, Ramaekers D. Neyt M, et al. Among authors: van brabandt h. Acta Cardiol. 2009 Feb;64(1):1-10. doi: 10.2143/AC.64.1.2034354. Acta Cardiol. 2009. PMID: 19317290 Review.

2

Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian context.

Neyt M, Thiry N, Ramaekers D, Van Brabandt H. Neyt M, et al. Among authors: van brabandt h. Appl Health Econ Health Policy. 2008;6(1):67-80. doi: 10.2165/00148365-200806010-00006. Appl Health Econ Health Policy. 2008. PMID: 18774871

3

Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literature.

Neyt M, Van Brabandt H, Devriese S, De Laet C. Neyt M, et al. Among authors: van brabandt h. Health Policy. 2009 Jul;91(2):107-20. doi: 10.1016/j.healthpol.2008.11.014. Epub 2009 Jan 9. Health Policy. 2009. PMID: 19135756 Review.

4

Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspective.

Neyt M, De Laet C, De Ridder A, Van Brabandt H. Neyt M, et al. Among authors: van brabandt h. Pharmacoeconomics. 2009;27(4):313-27. doi: 10.2165/00019053-200927040-00004. Pharmacoeconomics. 2009. PMID: 19485427

5

The cost-utility of catheter ablation of atrial fibrillation: a systematic review and critical appraisal of economic evaluations.

Neyt M, Van Brabandt H, Devos C. Neyt M, et al. Among authors: van brabandt h. BMC Cardiovasc Disord. 2013 Sep 26;13:78. doi: 10.1186/1471-2261-13-78. BMC Cardiovasc Disord. 2013. PMID: 24070126 Free PMC article. Review.

6

CARDIOVASCULAR SCREENING OF YOUNG ATHLETES: A REVIEW OF ECONOMIC EVALUATIONS.

Gerkens S, Van Brabandt H, Desomer A, Leonard C, Neyt M. Gerkens S, et al. Among authors: van brabandt h. Int J Technol Assess Health Care. 2017 Jan;33(1):76-83. doi: 10.1017/S0266462317000162. Epub 2017 Apr 24. Int J Technol Assess Health Care. 2017. PMID: 28436336 Review.

7

More is not better in the early care of acute myocardial infarction: a prospective cohort analysis on administrative databases.

Van Brabandt H, Camberlin C, Vrijens F, Parmentier Y, Ramaekers D, Bonneux L. Van Brabandt H, et al. Eur Heart J. 2006 Nov;27(22):2649-54. doi: 10.1093/eurheartj/ehl161. Epub 2006 Aug 4. Eur Heart J. 2006. PMID: 16891380

8

Percutaneous pulmonary and aortic valve insertion in Belgium: going for conditional reimbursement or waiting for further evidence?

Neyt M, Vinck I, Gewillig M, Van Brabandt H. Neyt M, et al. Among authors: van brabandt h. Int J Technol Assess Health Care. 2009 Jul;25(3):281-9. doi: 10.1017/S0266462309990080. Int J Technol Assess Health Care. 2009. PMID: 19619346 Review.

9

Safety of percutaneous aortic valve insertion. A systematic review.

Van Brabandt H, Neyt M. Van Brabandt H, et al. BMC Cardiovasc Disord. 2009 Sep 1;9:45. doi: 10.1186/1471-2261-9-45. BMC Cardiovasc Disord. 2009. PMID: 19723312 Free PMC article. Review.

10

Pitfalls in health-economic evaluations: the case of cost-effectiveness of prophylactic implantable cardioverter-defibrillator therapy in Belgium.

Van Brabandt H, Neyt M. Van Brabandt H, et al. Europace. 2009 Dec;11(12):1571-3. doi: 10.1093/europace/eup290. Epub 2009 Oct 8. Europace. 2009. PMID: 19819879 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters